Clinical Trial Design and Endpoints for Stage IV Melanoma in the Modern Era
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference34 articles.
1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016
2. High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993;Atkins;J Clin Oncol,1999
3. Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials;Korn;J Clin Oncol,2008
4. A landscape of driver mutations in melanoma;Hodis;Cell,2012
5. Genomic classification of cutaneous melanoma;Akbani;Cell,2015
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Time to next treatment or death as a candidate surrogate endpoint for overall survival in advanced melanoma patients treated with immune checkpoint inhibitors: an insight from the phase III CheckMate 067 trial;ESMO Open;2022-02
2. Long-term quality of life outcomes of women treated for early-stage endometrial cancer;International Journal of Gynecologic Cancer;2020-12-24
3. Can melatonin and its metabolites boost the efficacy of targeted therapy in patients with advanced melanoma?;Experimental Dermatology;2020-07-22
4. Immune-checkpoint inhibitors and candidate surrogate endpoints for overall survival across tumour types: A systematic literature review;Critical Reviews in Oncology/Hematology;2019-05
5. Ipilimumab in combination with nivolumab for the treatment of renal cell carcinoma;Expert Opinion on Biological Therapy;2018-08-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3